Biosimilars 2023 Year in Review


Since the passage of the Biologics Price Competition and Innovation Act, the field of biosimilars has expanded and evolved. Keeping abreast of these changes helps stakeholders understand future opportunities.

On January 30, 2024, life sciences attorneys Rae Crisler, Martina Hufnal, and Philip Chen will provide a comprehensive look at the U.S. biosimilars field in 2023. The webinar will cover:

  • The U.S. biosimilars market, including approvals and launches
  • Legislative and regulatory developments
  • Litigation and post-grant trends​

Additionally, our hosts will discuss other developments they anticipate in the biosimilars space in the coming year.

If you have any questions, please contact [email protected].